Warburg Pincus Hires Three EIRs in Healthcare Group
October 10, 2014
Warburg Pincus has appointed three professionals as executives-in-residence in the firm’s healthcare group: David Kirchhoff, Philip Gioia and Richard Hassett. The additions will explore investment opportunities in the healthcare industry, including the areas of consumer-driven healthcare, biopharmaceuticals and population health. Mr. Kirchhoff has more than 25 years of management experience, most recently serving as CEO of Weight Watchers International; Mr. Gioia has more than 25 years of experience in the U.S. pharmaceutical industry, previously serving as Glenmark Pharmaceuticals’ president of North America; and Dr. Hassett has nearly 30 years of healthcare experience as a clinician and a healthcare services executive, most recently as president and CEO of NovaSom.
David Kirchhoff, Executive-in-Residence, Healthcare